Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Koreaopen access
- Authors
- Kim, Min-Chan; Jung, Mi Ran; Noh, Jeong Ju; Kang, Sunghwa; Chung, Jae Hun; Park, Ji-Ho; Kim, Tae-Han; Park, Jae Kyun; Kim, Yoonhong; Seo, Sang Hyuk; Kim, Sung Eun; Kwon, Oh Kyung; Park, Ji Yeon; Park, Ki Bum; Hwang, Sun-Hwi; Lee, Si-Hak; Lee, Young-Joon; Jeong, Sang-Ho; Jeon, Tae-Yong; Kim, Dae Hwan; Choi, Chang In; Yoon, Ki Young; Seo, Kyung Won; Kim, Ki Hyun; Oh, Sang Hoon; Kim, Kwang Hee
- Issue Date
- Dec-2025
- Publisher
- 대한내시경복강경외과학회
- Keywords
- Anastomotic leak; Gastrectomy; Gastrointestinal endoscopy; Stomach neoplasms; Treatment outcome
- Citation
- Journal of Minimally Invasive Surgery, v.28, no.4, pp 184 - 192
- Pages
- 9
- Indexed
- SCOPUS
KCI
- Journal Title
- Journal of Minimally Invasive Surgery
- Volume
- 28
- Number
- 4
- Start Page
- 184
- End Page
- 192
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/81565
- DOI
- 10.7602/jmis.2025.28.4.184
- ISSN
- 2234-778X
2234-5248
- Abstract
- Purpose: Esophagojejunostomy leakage (EJL) remains one of the most critical complications following total gastrectomy for gastric cancer. This study aimed to evaluate the evolving therapeutic approaches and clinical outcomes of EJL using data from a large-scale multicenter retrospective cohort. Methods: Among 6,577 patients who underwent total gastrectomy or proximal gastrectomy with double tract reconstruction at nine institutions from 2003 to 2024, 196 (3.0%) developed EJL. Of these, 162 patients with comprehensive clinical data were included in the final analysis. The study examined treatment modalities, changes in management over time, patient characteristics, surgical variables, and clinical outcomes. Four groups were defined according to treatment approach: conservative, endoscopic, reoperation, and multimodal (combined) therapy. Results: Endoscopic therapy was first introduced in 2011 and has progressively supplanted reoperation, now comprising 32.5% of cases. The average time to EJL diagnosis was 8.4 days after surgery. Overall in-hospital mortality was 6.1% (10/162). When conservative management was excluded, endoscopic treatment demonstrated the highest rate of therapeutic success (94.3%, p = 0.004). Both the duration until diet resumption and length of hospital stay were notably reduced in the endoscopic and conservative groups compared with reoperation and multimodal therapy (p < 0.001). Moreover, although the highest post-leakage hospitalization costs were observed with multimodal treatment (p < 0.001), overall hospitalization expenses were significantly lower for patients managed conservatively or with endoscopic intervention (p < 0.001). Conclusion: Over the past two decades, management of EJL has shifted toward endoscopic approaches. Endoscopic therapies yield superior clinical outcomes and should be considered a primary option for appropriate candidates.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.